Literature DB >> 1398948

Lipid A in Helicobacter pylori.

I Mattsby-Baltzer1, Z Mielniczuk, L Larsson, K Lindgren, S Goodwin.   

Abstract

Free lipid A of Helicobacter pylori was characterized with regard to chemical composition, reactivity with anti-lipid A antibodies, and activity in a Limulus lysate assay. The predominant fatty acids of H. pylori lipid A were 3-OH-18:0, 18:0, 3-OH-16:0, 16:0, and 14:0. Hexosamine was present in amounts similar to those in Campylobacter jejuni or Salmonella typhimurium lipid A. The lipopolysaccharide of H. pylori contained 2-keto-3-deoxyoctonic acid, a common constituent of enterobacterial and C. jejuni lipopolysaccharides. In the enzyme-linked immunosorbent assay, the doses of lipid A required to inhibit anti-lipid A by 50% (EI50 values) by absorption of the immune (rabbit) serum were 7.9, 1.2, and 1.4 micrograms of O-deacylated lipid A's from H. pylori, C. jejuni, and S. typhimurium per ml, respectively. The lower reactivity of H. pylori lipid A compared with those of the other two lipid A preparations (as shown by the higher EI50 value) was underscored by the use of a murine monoclonal anti-lipid A antibody in the inhibition assay. An EI50 value was not obtained at the concentrations tested for H. pylori lipid A; the corresponding figures for C. jejuni and S. typhimurium lipid A's were 13 and 14 micrograms/ml, respectively. No inhibition was obtained with H. pylori lipopolysaccharide, which showed a low-molecular-weight profile on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The activity of H. pylori lipid A in the Limulus assay was approximately 71 and 650 times lower than those of C. jejuni and S. typhimurium lipid A's, respectively. These findings suggest that lipid A is an integral part of the outer cell wall of H. pylori. The lower reactivity of H. pylori lipid A with anti-lipid A antibodies and in the Limulus assay compared with that of C. jejuni or S. typhimurium lipid A may be explained by a different composition of the fatty acids, especially the 3-hydroxy fatty acids, and a possible deviating phosphorylation pattern.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1398948      PMCID: PMC257475          DOI: 10.1128/iai.60.10.4383-4387.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  The formation of 2-keto-3-deoxyheptonic acid in extracts of Escherichia coli B. I. Identification.

Authors:  A WEISSBACH; J HURWITZ
Journal:  J Biol Chem       Date:  1959-04       Impact factor: 5.157

Review 2.  Bacterial lipopolysaccharides: relationship of structure and conformation to endotoxic activity, serological specificity and biological function.

Authors:  E T Rietschel; L Brade; U Schade; U Seydel; U Zähringer; K Brandenburg; I Helander; O Holst; S Kondo; H M Kuhn
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

3.  Structure-activity relationship of lipid A: comparison of biological activities of natural and synthetic lipid A's with different fatty acid compositions.

Authors:  S Kanegasaki; K Tanamoto; T Yasuda; J Y Homma; M Matsuura; M Nakatsuka; Y Kumazawa; A Yamamoto; T Shiba; S Kusumoto
Journal:  J Biochem       Date:  1986-04       Impact factor: 3.387

Review 4.  Production of monoclonal antibodies: strategy and tactics.

Authors:  S F de StGroth; D Scheidegger
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

5.  Cellular fatty acids of Alcaligenes and Pseudomonas species isolated from clinical specimens.

Authors:  S B Dees; C W Moss
Journal:  J Clin Microbiol       Date:  1975-05       Impact factor: 5.948

6.  Low biological activity of Helicobacter pylori lipopolysaccharide.

Authors:  A Muotiala; I M Helander; L Pyhälä; T U Kosunen; A P Moran
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

7.  Lipid A and anti-lipid A.

Authors:  I Mattsby-Baltzer; B Kaijser
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

8.  Lipid A in anaerobic bacteria.

Authors:  G Dahlén; I Mattsby-Baltzer
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

9.  Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides.

Authors:  A P Moran; I M Helander; T U Kosunen
Journal:  J Bacteriol       Date:  1992-02       Impact factor: 3.490

10.  Cellular fatty acid composition of Campylobacter pylori from primates and ferrets compared with those of other campylobacters.

Authors:  C S Goodwin; W McConnell; R K McCulloch; C McCullough; R Hill; M A Bronsdon; G Kasper
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

View more
  14 in total

Review 1.  Structural modifications of Helicobacter pylori lipopolysaccharide: an idea for how to live in peace.

Authors:  Magdalena Chmiela; Eliza Miszczyk; Karolina Rudnicka
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

2.  Adjuvant activity of naturally occurring monophosphoryl lipopolysaccharide preparations from mucosa-associated bacteria.

Authors:  Paula M Chilton; Diana M Hadel; Thao T To; Thomas C Mitchell; Richard P Darveau
Journal:  Infect Immun       Date:  2013-06-24       Impact factor: 3.441

3.  Inability of the Francisella tularensis lipopolysaccharide to mimic or to antagonize the induction of cell activation by endotoxins.

Authors:  P Ancuta; T Pedron; R Girard; G Sandström; R Chaby
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

4.  Molecular structures that influence the immunomodulatory properties of the lipid A and inner core region oligosaccharides of bacterial lipopolysaccharides.

Authors:  P J Baker; T Hraba; C E Taylor; P W Stashak; M B Fauntleroy; U Zähringer; K Takayama; T R Sievert; X Hronowski; R J Cotter
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

5.  Microwave-assisted sample preparation for rapid and sensitive analysis of H. pylori lipid A applicable to a single colony.

Authors:  Ping Zhou; Vandana Chandan; Xin Liu; Kenneth Chan; Eleonora Altman; Jianjun Li
Journal:  J Lipid Res       Date:  2009-04-28       Impact factor: 5.922

6.  Helicobacter pylori lipopolysaccharide: biological activities in vitro and in vivo, pathological correlation to human chronic gastritis and peptic ulcer.

Authors:  Yi-Hui Luo; Jie Yan; Ya-Fei Mao
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

7.  Helicobacter pylori lipopolysaccharide binds to CD14 and stimulates release of interleukin-8, epithelial neutrophil-activating peptide 78, and monocyte chemotactic protein 1 by human monocytes.

Authors:  C M Bliss; D T Golenbock; S Keates; J K Linevsky; C P Kelly
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

8.  A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide.

Authors:  J E Somerville; L Cassiano; B Bainbridge; M D Cunningham; R P Darveau
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

9.  Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion.

Authors:  R P Darveau; M D Cunningham; T Bailey; C Seachord; K Ratcliffe; B Bainbridge; M Dietsch; R C Page; A Aruffo
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

10.  Helicobacter pylori with a truncated lipopolysaccharide O chain fails to induce gastritis in SCID mice injected with splenocytes from wild-type C57BL/6J mice.

Authors:  K A Eaton; S M Logan; P E Baker; R A Peterson; M A Monteiro; E Altman
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.